No trigger points for the share price, page-29

Ah Joey, Cephalon/Teva deal is dead. And the Japan deal is a small market. We need a big pharma deal to put us on the map again, Mesoblast FY result didnt get a mention in the AFR, (i dont think) we need the business world to be talking about MSB, and they were when we sign the Cephalon deal, in a positive way, when TEVA took over it started to get negative, and those being negative about TEVA were ultimately right.

We need a big pharma deal end of story, results will hopefully take care of themselves, but if we want a bump in the near term, we need the deal that Itescu keeps metioning is around the corner, although he failed to mention this last week, which concerns me.